Grand Rounds Recap 03.03.21


R4 Case Follow Up WITH Dr. Li

Following up on patients can be an educational experience

  • Can learn inpatient course

  • Can see if patient returns to ED if discharged

  • Can help tune your clinical sense

  • Dr. Kurt Smith was a prior resident at UCEM who followed up on every patient he saw during residency

    • Followed up on every patient he saw who was admitted and looked at ED diagnosis and discharge diagnosis

    • Had increasing percent matching diagnosis as he progressed through residency

  • Balancing best medical care and best thing for the patient

    • Case example of flying a patient on Air Care with concern for stroke whose family had no transportation to hospital, no telephone, and patient was aphasic

    • Risk and benefit decisions in real time for should we stop the helicopter so family can ride to the hospital, knowing this would increase time of transport and delay in treatment in case it was a time sensitive pathology such as ischemic stroke

  • Seeing next step management for admitted patients

    • Case of Ogilvie’s with dilated sigmoid to 24 cm

    • ED management includes labs, conservative treatment, involving consultants, and admission

    • Inpatient management included conservative treatment and then neostigmine

    • Ogilvie’s syndrome is also called acute colonic pseudo-obstruction

      • Perforation rates 1-3% with Ogilvies

      • When dilation of colon is over 14 cm, up to 23% may perforate

      • Perforation carries high mortality and morbidity

      • Patients typically have multiple comorbid conditions

      • Treatment:

        • Conservative: NPO, NG tube, rectal tube, electrolytes, rehydration

        • If refractory, neostigmine has been studied to be effective in rapid colonic decompression

        • If still no resolution, colonoscopy can be used

          • Technically difficult, and 3% perforation rate

        • If still no resolution, surgical cecostomy can performed

  • Don’t be afraid to get the appropriate consultant on board for predicted clinical course

    • Patient with large cellulitis and phlegmon or possible developing abscess on CT

    • Surgery was consulted and there was no abscess to drain at this time

    • Followed patient while inpatient

    • Eventually went to OR and drained 500cc of purulent material

  • Pathology takes time to present

    • Case of an ESRD patient presenting with chronic MSK pain

    • Troponin elevated and was admitted

    • 12 hours after initial ED presentation, became hypotensive

    • ESRD patients have a 100-300x mortality rate due to sepsis when compared to the general population


R1 Clinical Treatments: Migraines WITH Drs. Diaz and Shaw

Please see Dr. Diaz’s post that accompanies the lecture.

Migraine treatments beyond the ‘migraine cocktail’

  • Ketamine - Literature review and outcomes

    • Low Dose Ketamine Does not Improve Migraine in the ED: A Randomized Placebo-controlled Trial

      • Not better than placebo

    • The THINK (treatment of headache with intranasal ketamine trial): A randomized controlled trial comparing intranasal ketamine with IV metoclopramide

      • Ketamine not superior

    • A comparison of headache treatment in the ED: Prochlorperazine versus ketamine

      • Prochlorperazine was superior to ketamine

  • Propofol - Literature review and outcomes

    • Propofol for migraine in the ED: A pilot randomized controlled trial

      • Time to discharge was significantly lower in the propofol group

    • Propofol for treatment of acute migraine in the ED: a systematic review

      • Propofol is safe and has shown efficacy for migraine treatment

  • Valproic acid - Literature review and outcomes

    • Intravenous sodium valproate for acute migraine in the ED: a meta-analysis

      • Inferior to metoclopramide, ketorolac, and prochlorperazine

      • Comparable to dexamethasone and sumatriptan

  • Magnesium - Literature review and outcomes

    • Management of adults with acute migraine in the ED: The american headache society evidence assessment of parenteral pharmacotherapies

      • No recommendation can be made regarding the role of IV magnesium

    • Ketorolac vs. Magnesium sulfate in migraine headache pain management; a preliminary study

      • Magnesium was superior to ketorolac

    • MAGraine: Magnesium compared to conventional therapy for treatment of migraines

      • There was no difference between magnesium vs metoclopramide or prochlorperazine

  • Sphenopalatine Ganglion block - Literature review and outcomes

    • Sphenopalatine ganglion block for the treatment of acute migraine headache

      • The majority of patients were pain free after 15 min

    • Noninvasive sphenopalatine ganglion block for acute headache in the ED: a randomized placebo-controlled trial

      • There was no difference between groups (bupivacaine vs saline) assessed at 15 minutes. (Secondary analysis showed at 24 hours, more patients in bupivacaine group were headache free)

  • Droperidol - Literature review and outcomes

    • Droperidol for the treatment of acute migraine headaches

      • Droperidol performed at least as well as comparison drugs

  • Haloperidol - Literature review and outcomes

    • Treatment of headache in the ED: Haloperidol in the acute setting (The-HA study): a randomized trial

      • Haldol is more effective than placebo

    • A RCT of IV haloperidol vs IV metoclopramide for acute migraine therapy in the ED

      • Haldol is as effective as metoclopramide

  • IV fluids - Literature review and outcomes

    • IVF for the treatment of ED patients with migraine headache: a RCT

      • There was no difference between groups (1L NS vs 10mL NS)

  • Benadryl - Literature review and outcomes

    • A Randomized trial of diphenhydramine as prophylaxis against metoclopramide-induced akathisia in nauseated ED patients

      • Prophylactic diphenhydramine did not decrease the rate of akathisia

    • Diphenhydramine for the prevention of akathisia induced by prochlorperazine: a RCT

      • Adjunct diphenhydramine resulted reduction in the incidence of akathisia

    • Diphenhydramine in the treatment of akathisia induced by prochlorperazine

      • Diphenhydramine was associated with rapid improvement in symptoms

  • Antidopaminergics

    • Management of adults with acute migraine in the ED: The american headache society evidence assessment of parenteral pharmacotherapies

      • IV metoclopramide or prochlorperazine should be offered to adults in ED with acute migraine

    • IV metoclopramide vs dexketoprofen trometamol vs metoclopramide + dexketoprofen trometamol in acute migraine attack in the ED: a randomized double blind controlled trial

      • Combo treatment was superior to either medication

    • The efficacy and safety of prochlorperazine in patients with acute migraine: a systematic review and metaanalysis

      • Prochlorperazine was more effective than placebo and other active comparators

  • NSAIDs

    • Management of adults with acute migraine in the ED: The american headache society evidence assessment of parenteral pharmacotherapies

      • IV ketorolac may be offered to adults who present to an ED with acute migraine

    • Ketorolac in the treatment of acute migraine: a systematic review

      • Ketorolac may not offer benefit over other standard migraine therapies

  • Triptans

    • Management of adults with acute migraine in the ED: The american headache society evidence assessment of parenteral pharmacotherapies

      • Subcutaneous sumatriptan should be offered to adults who present to the ED with acute migraine

      • Not for patients with cardiovascular risk factors or active chest pain


R2 CPC WITH Drs. Gressick and Roche

Case: Middle aged female with hx of hep C presents with AMS. Found down at home. Abrasions to face. EMS narcan with possible response.

  • Vitals show tachypnea and SpO2 96% on 4L NC. Afebrile and HDS

  • Physical exam shows: abrasions on face, minimally responsive female, bruising on both thighs, abrasions on knees and ankles, pupils 2-3mm bilaterally and responsive. Eyes have a downward gaze. Grimaces and turns head from side to side in response to noxious stimuli.

  • Lab studies shows: Mild respiratory alkalosis, normal glucose, minimal ast/alt elevation, BMP unremarkable, mild leukocytosis 12.3, ingestion labs normal, EKG unremarkable

  • Imaging studies show: CXR with nonspecific basilar airspace disease, XR of ankles show no acute fractures, CT head, c-spine, CTA head and neck were normal, CT max face normal, CT chest showed retained airway secretions, CT abd/pel showed ‘diarrheal state’

  • Moved to SRU. Given broad spectrum antibiotics. Vomited.

picture.png
  • A test was ordered… 

    • Urine drug screen

    • Diagnosis: polysubstance overdose with trauma

    • Admitted to MICU. Narcan drip. EEG and MRI negative.

    • Discharged on HD#4 with a normal mental status

  • Management of Long Acting Opioid Overdose

    • Methadone has a half life of 8-59 hours

    • Adverse effects includes arrhythmias such as torsades

    • Urine methadone and serum methadone levels do not correlate well. Typically has no impact on clinical course or ED treatment

    • Not all lab UDS tests for synthetic opioids such as methadone

    • Naloxone has a short half life, about 0.5-2 hours depending on route of administration

      • Narcan drip: titrate to effect

      • There is an MDcalc calculator where you input the initial bolus dose and it helps give an hourly rate to start with


Air Care Grand Rounds WITH Drs. Hinckley, Gottula, Skrobut

Trauma with Dr. Hinckley

  • MARCH algorithm

    • Massive (external compressible) hemorrhage

      • Direct pressure

      • Devices

        • Tourniquet, combat gauze, T-pod

          • Physical exam sensitivity for pelvic fracture is 26%

          • Specificity is 99%

          • Stabilize the pelvis of any patient with a blunt mechanism and pelvic injury/instability on exam, hemorrhagic shock and pelvic/low back pain, hemorrhagic shock and AMS

    • Airway

    • Respiratory

      • The big question: is there a tension pneumo or hemothorax

        • Thoracostomy

          • Needle > 14 gauge

          • Anatomic landmarks

            • 100% at 5th ICS vs 57.5% at 2nd ICS (success rate at these locations on a cadaver study)

            • We’ve moved to anterior/mid axillary line at the 5th ICS at Aircare

            • Helps avoid big vessels in mediastinum at 2nd ICS

          • Indications

            • Spontaneously breathing

              • Awake: progressive severe respiratory distress with hypoxia

              • Comatose: progressive severe hypoxic respiratory failure AND

                • At least 2 indicators of a PTX

                • Chest wall trauma

                • decreased/absent breath sounds

                • Ultrasound evidence of PTX

                • JVD

                • Tracheal deviation

              • Traumatic cardiac arrest

          • Needle vs finger

            • Finger thoracostomy gives consistent access to pleural space

            • Re-expansion visually and tactically confirmed

            • Avoids re-tension by obstruction

          • Indications for finger

            • Traumatic cardiac arrest

            • Refractory tension physiology despite needle attempts

    • Circulation

      • TXA

        • MATTERs study: overall 30 day mortality 17.4% v 23.9%, NNT = 15, no fatalities from VTE

        • CRASH-2: Mortality 14.5% vs 16% (p=0.0035)

        • Time to TXA, quicker = mortality benefit

        • Air Care Indications

          • Opening blood cooler and less than 3 hours from trauma

      • Blood products (2 liquid plasma, 2 pRBC)

        • Give when there is hemodynamic instability

          • Trauma

          • GI/Ob/surgical and other hemorrhages

        • Liquid plasma can help with warfarin reversal as well

        • Air Care Indications

          • Concern for hemorrhagic shock based on HPI/PE/mechanism and at least 1 of the following:

            • Shock index >1

            • SBP < 90

            • Provider gestalt (worsening AMS, +FAST, low ETCO2, high glucose, elevated lactate, etc)

        • Actively warm to avoid hypothermia

        • Avoid crystalloid

        • Goal SBP >90 or MAP >65

          • If TBI, ‘permissive hypotension’ is contraindicated. Aim for normotension

        • Do not wait for hemoglobin drop

    • Head Injury/Hypothermia

  • Prehospital Obstetric Trauma with Dr. Gottula

    • General Rule #1 = cant have a stable fetus without a stable mom

      • Prioritize stabilizing maternal status

    • General Rule #2 = should I be giving this life saving medication to a pregnant woman?

      • Nearly every med that would benefit the prehospital pregnant patient is safe and beneficial. ACOG supports this

    • General Rule #3 = healthy pregnant women look healthy… until they don’t

    • General Rule #4 = Know how much blood she has lost and communicate with receiving facility

      • From time of onset

      • How much at home? En route? 

    • Obstetric trauma occurs in 1/12 pregnancies

    • ⅔ is MVCs

    • No other single diagnosis has a higher mortality in pregnancy

    • ⅓ admitted will deliver during that admission

    • Stick to MARCH, approach this systematically, focus on maternal stabilization

    • Airway

      • Increased nasopharyngeal edema, have suction ready

      • Enlarged tongue and epiglottis, consider decreasing ETT size

      • Increase risk of gastric aspiration

    • Breathing

      • Increased RR, TV, MV, O2 consumption

      • Decreased FRC, arterial PCO2, serum bicarb, respiratory compliance

      • Goal O2 sat > 95%

      • If thoracostomy is needed, do two ICS higher in patients >20 weeks pregnant

    • Circulation

      • Increased plasma volume (40-50%), erythrocyte volume (20%), HR, Cardiac output

      • Decreased supine venous return, arterial blood pressure, SVR

      • If blood is required, O- blood should be used

      • Placental abruption

        • When mom survives, this is the most common cause of fetal death

        • Painful vaginal bleeding, though bleeding can be ‘concealed’

        • US is not sensitive for diagnosis

    • Fetal monitoring

      • Continuous monitoring should be initiated ASAP

      • ACOG recommends at least 2-6 hours

  • Walk Around Training with Lead Pilot Bob Francis

    • Inspections

      • Shore power cord disconnected

      • Doors and access panels secured

      • Cowlings and latches secured

      • Fuel cap secured

      • Condition of all air intake screens

      • Check for evidence of fluid leakage

      • Condition and security of take off area

  • Air Care pediatric trauma simulation with Dr. Skrobut

    • Pediatric shock can be more subtle and may only present with tachycardia and prolonged capillary refill. Be sure to transfuse compensated hemorrhagic shock.

    • The pediatric FAST exam is less sensitive than in adults. You can improve sensitivity by doing serial exams-- especially for any decompensation.

    • Dosing for blood and plasma is 10cc/kg. Be sure to set up a push pull system by using a three way stopcock and 60cc syringe between blood tubing and buddy light warmer to ensure proper dosing. Repeat as needed. 

    • TXA data isnt as robust in children but still part of our protocol. Dosing is 15mg/kg max 1g

    • Hypertonic saline dosing is 3-4cc/kg

    • Always be sure to have a reference card or application ready for equipment selection, medication dosing, and vent settings. It is best to write these down for your patient before you arrive at the scene.